• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Lowell E. Schnipper, MD


  • Schnipper LE.Quality oncology practice initiative: an approach to solving the value equation.J Oncol Pract. 2014 May;10(3):219-20.
  • Ellis LM, Bernstein DS, Voest EE, Berlin JD, Sargent D, Cortazar P, Garrett-Mayer E, Herbst RS, Lilenbaum RC, Sima C, Venook AP, Gonen M, Schilsky RL, Meropol NJ, Schnipper LE.American society of clinical oncology perspective: raising the bar for clinical trials by defining clinically meaningful outcomes.J Clin Oncol. 2014 Apr 20;32(12):1277-80.
  • Shih YC, Ganz PA, Aberle D, Abernethy A, Bekelman J, Brawley O, Goodwin JS, Hu JC, Schrag D, Temel JS, Schnipper L.Delivering high-quality and affordable care throughout the cancer care continuum.J Clin Oncol. 2013 Nov 10;31(32):4151-7.
  • Schnipper LE.The rising cost of cancer care: physicians take charge.J Oncol Pract. 2012 Jul;8(4):e87-8.
  • Peppercorn JM, Smith TJ, Helft PR, Debono DJ, Berry SR, Wollins DS, Hayes DM, Von Roenn JH, Schnipper LE, .American society of clinical oncology statement: toward individualized care for patients with advanced cancer.J Clin Oncol. 2011 Feb 20;29(6):755-60.
  • LoRusso PM, Schnipper LE, Stewart DJ, Boerner SA, Averbuch SD, Wolf W.Translating clinical trials into meaningful outcomes.Clin Cancer Res. 2010 Dec 15;16(24):5951-5. Review.
  • Schnipper LE, Meropol NJ, Brock DW.Value and cancer care: toward an equitable future.Clin Cancer Res. 2010 Dec 15;16(24):6004-8. Review.
  • Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM, Blum D, Ubel PA, Schnipper LE, .American Society of Clinical Oncology guidance statement: the cost of cancer care.J Clin Oncol. 2009 Aug 10;27(23):3868-74.
  • Schnipper LE.Update in oncology.Ann Intern Med. 2007 Dec 4;147(11):775-82. Review.
  • Miksad RA, Schnipper L, Goldstein M.Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value?.J Clin Oncol. 2007 Oct 1;25(28):4506-7; author reply 4508.
  • Pentz RD, Joffe S, Emanuel EJ, Schnipper LE, Haskell CM, Tannock IF.ASCO core values.J Clin Oncol. 2006 Dec 20;24(36):5780-2.
  • Li FP, Fletcher JA, Heinrich MC, Garber JE, Sallan SE, Curiel-Lewandrowski C, Duensing A, van de Rijn M, Schnipper LE, Demetri GD.Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred.J Clin Oncol. 2005 Apr 20;23(12):2735-43.
  • Gilligan TD, Carrington MA, Sellers TP, Casal L, Schnipper LE, Li FP.Cancer survivorship issues for minority and underserved populations.Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):284s-286s.
  • Merchan JR, Chan B, Kale S, Schnipper LE, Sukhatme VP.In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril.J Natl Cancer Inst. 2003 Mar 5;95(5):388-99.
  • Eder JP, Supko JG, Clark JW, Puchalski TA, Garcia-Carbonero R, Ryan DP, Shulman LN, Proper J, Kirvan M, Rattner B, Connors S, Keogan MT, Janicek MJ, Fogler WE, Schnipper L, Kinchla N, Sidor C, Phillips E, Folkman J, Kufe DW.Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily.J Clin Oncol. 2002 Sep 15;20(18):3772-84.
  • Vonderheide RH, Schultze JL, Anderson KS, Maecker B, Butler MO, Xia Z, Kuroda MJ, von Bergwelt-Baildon MS, Bedor MM, Hoar KM, Schnipper DR, Brooks MW, Letvin NL, Stephans KF, Wucherpfennig KW, Hahn WC, Nadler LM.Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals.Cancer Res. 2001 Dec 1;61(23):8366-70.
  • Schnipper LE, Strom TB.A magic bullet for cancer--how near and how far?.N Engl J Med. 2001 Jul 26;345(4):283-4.
  • Hilden JM, Emanuel EJ, Fairclough DL, Link MP, Foley KM, Clarridge BC, Schnipper LE, Mayer RJ.Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey.J Clin Oncol. 2001 Jan 1;19(1):205-12.
  • Elias A, Ibrahim J, Skarin AT, Wheeler C, McCauley M, Ayash L, Richardson P, Schnipper L, Antman KH, Frei E.Dose-intensive therapy for limited-stage small-cell lung cancer: long-term outcome.J Clin Oncol. 1999 Apr;17(4):1175.
  • Chan CY, Molrine DC, Antin JH, Wheeler C, Guinan EC, Weinstein HJ, Phillips NR, McGarigle C, Harvey S, Schnipper C, Ambrosino DM.Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT).Bone Marrow Transplant. 1997 Jul;20(1):33-8.
  • Wheeler C, Eickhoff C, Elias A, Ibrahim J, Ayash L, McCauley M, Mauch P, Schwartz G, Eder JP, Mazanet R, Ferrara J, Rimm IJ, Guinan E, Bierer B, Gilliland G, Churchill WH, Ault K, Parsons S, Antman K, Schnipper L, Tepler I, Gaynes L, Frei E 3rd, Kadin M, Antin J.High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.Biol Blood Marrow Transplant. 1997 Jun;3(2):98-106.
  • Drews RE, Kolker MT, Sachar DS, Moran CP, Schnipper LE.Passage to nonselective media transiently alters growth of mycophenolic acid-resistant mammalian cells expressing the escherichia coli xanthine-guanine phosphoribosyltransferase gene: implications for sequential selection strategies.Anal Biochem. 1996 Mar 15;235(2):215-26.
  • Eder JP, Chan VT, Ng SW, Rizvi NA, Zacharoulis S, Teicher BA, Schnipper LE.DNA topoisomerase II alpha expression is associated with alkylating agent resistance.Cancer Res. 1995 Dec 15;55(24):6109-16.
  • Ng SW, Eder JP, Schnipper LE, Chan VT.Molecular cloning and characterization of the promoter for the Chinese hamster DNA topoisomerase II alpha gene.J Biol Chem. 1995 Oct 27;270(43):25850-8.
  • Tepler I, Schwartz G, Parker K, Charette J, Kadin ME, Woodworth TG, Schnipper LE.Phase I trial of an interleukin-2 fusion toxin (DAB486IL-2) in hematologic malignancies: complete response in a patient with Hodgkin's disease refractory to chemotherapy.Cancer. 1994 Feb 15;73(4):1276-85.
  • Antman K, Ayash L, Elias A, Wheeler C, Schwartz G, Mazanet R, Tepler I, Schnipper LE, Frei E.High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age.J Natl Cancer Inst Monogr. 1994(16):91-4.